Condition
Epidermal Nevi
Total Trials
2
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
Treatment Research
2 treatments under study, led by Nfx179 Gel 150
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 2 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Early Phase 1 (1)
Phase 2 (1)
Trial Status
Withdrawn1
Not Yet Recruiting1
Clinical Trials (2)
Showing 2 of 2 trials
NCT07813533Early Phase 1Not Yet RecruitingPrimary
A Pilot Study to Examine the Efficacy and Tolerability of Sirolimus on Epidermal Nevi Lesions in Patients 6 Years Old and Above.
NCT05195762Phase 2WithdrawnPrimary
12-week Study of NFX-179 Gel in Subjects With Epidermal Nevi
Showing all 2 trials
Research Network
Common Treatments
- Nfx179 Gel 1501
- Sirolimus1
Active Sponsors
- Albert Chiou1
- NFlection Therapeutics, Inc.1
- Northwestern University1
Top Investigators
Stanford University
Northwestern University
Related Conditions
- Nevus Sebaceus1